Zurich Cantonal Bank’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-151
Closed -$343 2637
2024
Q4
$343 Sell
151
-647
-81% -$2.27K ﹤0.01% 2635
2024
Q3
$3.77K Sell
798
-3,465
-81% -$20K ﹤0.01% 2632
2024
Q2
$31.9K Sell
4,263
-1,289
-23% -$15.8K ﹤0.01% 2574
2024
Q1
$94.7K Buy
5,552
+813
+17% +$17.4K ﹤0.01% 2409
2023
Q4
$108K Sell
4,739
-2,800
-37% -$47.1K ﹤0.01% 2409
2023
Q3
$115K Buy
+7,539
New +$103K ﹤0.01% 2293

Other funds holding CABA

Zurich Cantonal Bank's CABA Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 151 shares — an estimated $343 sold.

Zurich Cantonal Bank first reported a position in CABA in Q3 2023 and held it in 6 quarters. The position peaked at $115K in Q3 2023. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 151 Cabaletta Bio shares in Q1 2025, an estimated $343.
  • Zurich Cantonal Bank first reported a position in Cabaletta Bio in Q3 2023 and held it in 6 quarters.
  • Zurich Cantonal Bank's Cabaletta Bio position peaked at $115K in Q3 2023.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.